COGNITION THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 USD | -3.41% |
|
-15.42% | -8.11% |
| 07/06 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
| 29/05 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
Chart calendar Cognition Therapeutics, Inc.
0742fa31f4ae360712.0UjdCuZ7ps4JwfdhmBMamcgZmvyr4ihmdfOtnFLP8nI.tXmpZZRW0oo9rM8F73xi06BRo7rgjUM-O6KfqRacmS2-P6x40UmVqnuyug~b317ced1d53a05daab90bcfa84ec122a
Upcoming events on Cognition Therapeutics, Inc.
Past events on Cognition Therapeutics, Inc.
| 07/06/2024 06:30 pm | Annual General Meeting |
| 07/05/2024 05:00 pm | Q1 2024 Earnings Release |
| 12/04/2024 05:30 pm | Investor Meeting - Key Opinion Leader |
| 11/04/2024 05:30 pm | Needham Healthcare Conference |
| 26/03/2024 05:30 pm | Q4 2023 Earnings Call |
| 26/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 08/03/2024 | Alzheimer and Parkinson Diseases International Conference |
| 06/03/2024 | Alzheimer and Parkinson Diseases International Conference |
| 05/03/2024 | Alzheimer and Parkinson Diseases International Conference |
| 05/03/2024 01:20 am | TD Cowen Health Care Conference |
| 15/11/2023 | Society For Neuroscience Meeting - Session PSTR527 |
| 14/11/2023 | Society For Neuroscience Meeting - Session PSTR402 |
| 14/11/2023 | Society For Neuroscience Meeting - Session PSTR402 |
| 02/11/2023 05:00 pm | Q3 2023 Earnings Release |
| 26/09/2023 06:50 pm | Cantor Global Healthcare Conference |
| 20/09/2023 01:40 am | Longwood Healthcare Leaders Fall Conference |
| 14/09/2023 01:30 am | H.C. Wainwright Global Investment Conference |
| 08/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 08/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 28/06/2023 05:30 pm | CT1812 Phase 2 Study Results Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -28,6 -24,0 -19.32% | -43,6 -47,5 8.38% | -50,7 -51,7 1.8% | -61,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -11,7 -5,20 -125.31% | -21,4 -22,2 3.42% | -25,8 -27,8 7.3% | -36,9 |
|
Net income Million USD | Released Forecast Spread | -12,1 | -16,2 -9,50 -71.03% | -21,4 -22,2 3.42% | -25,8 -27,8 7.3% | -36,9 |
|
EPS USD | Released Forecast Spread | -7,35 | -3,13 -0,49 -538.78% | -0,91 -0,92 1.09% | -0,86 -0,93 7.28% | -0,95 |
| Announcement Date | 07/05/21 | 30/03/22 | 23/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,41 -10,5 10.59% | -12,2 -9,63 -26.84% | -12,6 -12,9 2.2% | -9,30 -13,2 29.33% | -8,97 -10,5 14.24% | -11,8 -11,4 -4.01% | -14,7 -14,2 -3.76% | -15,2 -16,1 5.77% | -14,1 -15,7 9.96% | -15,1 | -16,1 | -15,5 | -18,3 | -19,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,71 -6,05 38.61% | -5,88 -7,41 20.68% | -6,63 -8,76 24.39% | -5,18 -5,94 12.81% | -6,17 -5,65 -9.28% | -4,73 -6,22 24% | -6,75 -8,26 18.26% | -8,14 -10,2 19.96% | -9,15 -8,52 -7.39% | -8,69 | -9,45 | -9,68 | -12,3 | -13,2 |
|
Net income Million USD | Released Forecast Spread | -3,84 -6,45 40.48% | -5,75 -7,41 22.37% | -6,63 -8,76 24.39% | -5,18 -5,94 12.81% | -6,17 -5,65 -9.28% | -4,73 -6,22 24% | -6,75 -8,26 18.26% | -8,14 -10,2 19.96% | -9,15 -8,52 -7.39% | -8,69 | -9,45 | -9,70 | -12,3 | -13,2 |
|
EPS USD | Released Forecast Spread | -0,17 -0,29 40.7% | -0,25 -0,32 21.88% | -0,29 -0,38 24.35% | -0,20 -0,23 11.11% | -0,21 -0,18 -18.87% | -0,16 -0,19 15.79% | -0,22 -0,24 7.37% | -0,27 -0,31 11.96% | -0,27 -0,25 -9.46% | -0,24 | -0,23 | -0,22 | -0,26 | -0,28 |
| Announcement Date | 11/05/22 | 09/08/22 | 14/11/22 | 23/03/23 | 04/05/23 | 08/08/23 | 02/11/23 | 26/03/24 | 07/05/24 | - | - | - | - | - |
More events
Past sector events for Cognition Therapeutics, Inc.
| 05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CGTX Stock
- Calendar Cognition Therapeutics, Inc.
